Prasanta Kumar Dash Ph.D.
Prasanta Kumar Dash Ph.D.
Assistant Professor
Verified email at
Cited by
Cited by
Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice
PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ...
Nature communications 10 (1), 1-20, 2019
Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages
I Kadiu, P Narayanasamy, PK Dash, W Zhang, HE Gendelman
The Journal of Immunology 189 (2), 744-754, 2012
Loss of neuronal integrity during progressive HIV-1 infection of humanized mice
PK Dash, S Gorantla, HE Gendelman, J Knibbe, GP Casale, E Makarov, ...
Journal of Neuroscience 31 (9), 3148-3157, 2011
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ...
Aids 26 (17), 2135-2144, 2012
Creation of a long-acting nanoformulated dolutegravir
B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ...
Nature communications 9 (1), 443, 2018
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ...
Biomaterials 151, 53-65, 2018
Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India
NB Siddappa, PK Dash, A Mahadevan, N Jayasuryan, F Hu, B Dice, ...
Journal of clinical microbiology 42 (6), 2742-2751, 2004
Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
P Puligujja, SS Balkundi, LM Kendrick, HM Baldridge, JR Hilaire, ...
Biomaterials 41, 141-150, 2015
Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice
U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ...
The Journal of infectious diseases 206 (10), 1577-1588, 2012
Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice
MD Boska, PK Dash, J Knibbe, AA Epstein, SP Akhter, N Fields, R High, ...
Molecular neurodegeneration 9, 1-18, 2014
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs
DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ...
The Journal of clinical investigation 127 (3), 857-873, 2017
Neuroprotective activities of CEP-1347 in models of neuroAIDS
D Eggert, PK Dash, S Gorantla, H Dou, G Schifitto, SB Maggirwar, ...
The journal of immunology 184 (2), 746-756, 2010
HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1
C Bethel-Brown, H Yao, S Callen, YH Lee, PK Dash, A Kumar, S Buch
The Journal of Immunology 186 (7), 4119-4129, 2011
Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution
BD Kevadiya, C Woldstad, BM Ottemann, P Dash, BR Sajja, B Lamberty, ...
Theranostics 8 (1), 256, 2018
Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
AA Epstein, P Narayanasamy, PK Dash, R High, SPR Bathena, ...
Journal of Neuroimmune Pharmacology 8, 1224-1238, 2013
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy
G Zhang, D Guo, PK Dash, M Araínga, JL Wiederin, NA Haverland, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 109-122, 2016
HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation
SS Gadad, RE Rajan, P Senapati, S Chatterjee, J Shandilya, PK Dash, ...
Journal of molecular biology 410 (5), 997-1007, 2011
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders
D Eggert, PK Dash, N Serradji, CZ Dong, P Clayette, F Heymans, H Dou, ...
Journal of neuroimmunology 213 (1-2), 47-59, 2009
Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India
NB Siddappa, PK Dash, A Mahadevan, A Desai, N Jayasuryan, V Ravi, ...
Aids 19 (13), 1426-1429, 2005
Creation of a long-acting rilpivirine prodrug nanoformulation
JR Hilaire, AN Bade, B Sillman, N Gautam, J Herskovitz, BLD Shetty, ...
Journal of controlled release 311, 201-211, 2019
The system can't perform the operation now. Try again later.
Articles 1–20